LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,330,000 | -14.4% | 48,250 | -0.5% | 0.51% | -21.4% |
| Q1 2021 | $7,396,000 | -18.7% | 48,515 | -47.0% | 0.65% | -16.1% |
| Q4 2020 | $9,099,000 | -8.9% | 91,493 | -12.7% | 0.77% | -8.1% |
| Q3 2020 | $9,987,000 | -19.3% | 104,778 | -5.3% | 0.84% | -23.1% |
| Q2 2020 | $12,381,000 | -27.6% | 110,689 | -26.1% | 1.10% | -13.1% |
| Q2 2019 | $17,098,000 | -10.9% | 149,786 | -1.9% | 1.26% | -10.1% |
| Q1 2019 | $19,200,000 | +27.2% | 152,729 | +37.3% | 1.40% | -1.1% |
| Q4 2018 | $15,099,000 | -19.9% | 111,266 | +62.0% | 1.42% | -3.5% |
| Q3 2018 | $18,857,000 | +0.9% | 68,699 | -23.9% | 1.47% | +13.8% |
| Q2 2018 | $18,698,000 | +18.2% | 90,254 | -5.8% | 1.29% | +10.9% |
| Q1 2018 | $15,823,000 | +28.8% | 95,806 | +6.8% | 1.16% | +34.2% |
| Q4 2017 | $12,289,000 | +45.9% | 89,748 | +45.1% | 0.87% | -9.6% |
| Q3 2017 | $8,422,000 | -2.0% | 61,859 | -12.6% | 0.96% | +10.9% |
| Q2 2017 | $8,596,000 | +27.0% | 70,809 | +10.7% | 0.87% | +29.3% |
| Q1 2017 | $6,770,000 | +4.5% | 63,961 | +0.3% | 0.67% | +14.5% |
| Q4 2016 | $6,479,000 | +0.1% | 63,765 | +0.6% | 0.58% | +18.2% |
| Q3 2016 | $6,471,000 | +84.3% | 63,399 | +115.3% | 0.50% | +53.7% |
| Q2 2016 | $3,512,000 | -14.1% | 29,444 | -22.9% | 0.32% | -20.9% |
| Q1 2016 | $4,089,000 | +101.0% | 38,182 | +103.5% | 0.41% | +86.7% |
| Q4 2015 | $2,034,000 | +49.8% | 18,759 | +18.3% | 0.22% | +20.4% |
| Q3 2015 | $1,358,000 | -61.4% | 15,856 | -54.5% | 0.18% | -58.5% |
| Q2 2015 | $3,518,000 | +97.1% | 34,871 | +50.6% | 0.44% | +52.4% |
| Q1 2015 | $1,785,000 | +113.3% | 23,151 | +47.2% | 0.29% | +127.0% |
| Q4 2014 | $837,000 | -6.2% | 15,723 | -17.2% | 0.13% | +5.9% |
| Q3 2014 | $892,000 | -21.1% | 18,978 | +4.6% | 0.12% | -15.6% |
| Q2 2014 | $1,130,000 | +17.0% | 18,147 | +26.4% | 0.14% | +1.4% |
| Q1 2014 | $966,000 | – | 14,362 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |